Company building sales as per prior period reporting. Proof has been supplied and is now becoming material.
Approx $1 million in sales revenue for the quarter plenty of ongoing development.
Well done BXN management! BXN are going places, look out once China comes to fruition! Anticipate a slow re-rate to recent highs and a gradual move forward from there as further company sales developments are announced.
Highlights of the Quarterly activities report.
29 October 2018QUARTERLY REPORT FOR THE PERIOD ENDED 30 SEPTEMBER 2018
Bioxyne Limited (ASX Code: BXN) (Bioxyne or the Company) is pleased to report on its activitiesfor the quarter ended 30 September 2018.Highlights
• Revenue for the quarter was $975,080, 72% stronger than the quarterly average forFY2018.
• Successful completion of Indonesian direct sales acquisition
• Active ongoing business development
Ann: Quarterly Activities Report, page-3
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
